Rubius Therapeutics to Acquire Manufacturing Facility in Smithfield, Rhode Island to Produce Red Cell Therapeutics

Rubius Therapeutics (NASDAQ:RUBY) has announced it has signed a purchase agreement to acquire a 135,000 square foot manufacturing facility in Smithfield, Rhode Island. As quoted in the press release: The company plans to invest up to $ 95 million through 2020, and up to $ 155 million in total over a five-plus year period, and […]